BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND ZFHX3, ATBT, 463, ENSG00000140836, Q15911 AND Prognosis
32 results:

  • 1. Risk factors for cervical lymph node metastasis in the central or lateral cervical region in medullary thyroid carcinoma: a systematic review and meta-analysis.
    Lin X; Huo J; Su H; Zhu C; Xu Y; Zhang F
    Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):547-561. PubMed ID: 37801162
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Better survival was found in patients treated with breast-conserving surgery compared with mastectomy in malignant phyllodes tumor of the breast.
    Chen CY; Ya-Chen
    Updates Surg; 2024 Jan; 76(1):265-270. PubMed ID: 37289397
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Validation of quantitative prognostic prediction using ADV score for resection of hepatocellular carcinoma: A Korea-Japan collaborative study with 9200 patients.
    Kang WH; Hwang S; Kaibori M; Kim JM; Kim KS; Kobayashi T; Kayashima H; Koh YS; Kubota K; Mori A; Takeda Y; Yun SS; Matsui K; Toriguchi K; Nagano H; Yoon MH; Soejima Y; Ariizumi S; Kim BS; Park Y; Yu HC; Kim BW; Lee JB; Park SJ; Jang JY; Yamaue H; Nakamura M; Yamamoto M; Endo I; ;
    J Hepatobiliary Pancreat Sci; 2023 Aug; 30(8):993-1005. PubMed ID: 36808234
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. High SURF4 expression is associated with poor prognosis of breast cancer.
    Zhai J; Han J; Li C; Guo F; Ma F; Xu B
    Aging (Albany NY); 2022 Nov; 14(22):9317-9337. PubMed ID: 36446386
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Primary and Secondary breast Sarcoma: Clinical and Pathological Characteristics, Prognostic Factors, and Nomograms for Predicting Survival.
    Osman MH; Rabie NA; Elmehrath AO; Bedair HM; Fala SY; Ghaith HS; Refaat MA
    Clin Breast Cancer; 2022 Oct; 22(7):e753-e763. PubMed ID: 35963779
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Alpha-mangostin as an inhibitor of GSK3β in triple-negative breast cancer.
    Dewi C; Fristiohady A; Amalia R; Bunggulawa EJ; Muchtaridi M
    J Biomol Struct Dyn; 2023 Jul; 41(10):4515-4521. PubMed ID: 35465844
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer.
    Althobiti M; El-Sharawy KA; Joseph C; Aleskandarany M; Toss MS; Green AR; Rakha EA
    Breast Cancer Res Treat; 2021 Oct; 189(3):621-630. PubMed ID: 34453638
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Insufficient examined lymph node count underestimates staging in pN3a patients after curative gastrectomy: a multicenter study with external validation.
    Dong Y; Qiu Y; Deng J; Wang W; Sun Z; Wang Z; Zhou Z; Xu H; Liang H
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):515-528. PubMed ID: 31813005
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Hypothyroidism and the risk of breast cancer recurrence and all-cause mortality - a Danish population-based study.
    Falstie-Jensen AM; Kjærsgaard A; Lorenzen EL; Jensen JD; Reinertsen KV; Dekkers OM; Ewertz M; Cronin-Fenton DP
    Breast Cancer Res; 2019 Mar; 21(1):44. PubMed ID: 30902106
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
    Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
    Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Integrated network analysis and machine learning approach for the identification of key genes of triple-negative breast cancer.
    Naorem LD; Muthaiyan M; Venkatesan A
    J Cell Biochem; 2019 Apr; 120(4):6154-6167. PubMed ID: 30302816
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Discordance between oncotype DX recurrence score and RSPC for predicting residual risk of recurrence in ER-positive breast cancer.
    Dodson A; Okonji D; Assersohn L; Rigg A; Sheri A; Turner N; Smith I; Parton M; Dowsett M
    Breast Cancer Res Treat; 2018 Feb; 168(1):249-258. PubMed ID: 29128896
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinical significance of preoperative serum albumin level for prognosis in surgically resected patients with non-small cell lung cancer: Comparative study of normal lung, emphysema, and pulmonary fibrosis.
    Miura K; Hamanaka K; Koizumi T; Kitaguchi Y; Terada Y; Nakamura D; Kumeda H; Agatsuma H; Hyogotani A; Kawakami S; Yoshizawa A; Asaka S; Ito KI
    Lung Cancer; 2017 Sep; 111():88-95. PubMed ID: 28838406
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Influence of comorbidity on chemotherapy use for early breast cancer: systematic review and meta-analysis.
    Edwards MJ; Campbell ID; Lawrenson RA; Kuper-Hommel MJ
    Breast Cancer Res Treat; 2017 Aug; 165(1):17-39. PubMed ID: 28528451
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. BRCA2 mutations should be screened early and routinely as markers of poor prognosis: evidence from 8,988 patients with prostate cancer.
    Cui M; Gao XS; Gu X; Guo W; Li X; Ma M; Qin S; Qi X; Xie M; Peng C; Bai Y
    Oncotarget; 2017 Jun; 8(25):40222-40232. PubMed ID: 28410213
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Outcomes of patients with breast cancer in function of their body mass index].
    Boivin L; Diguisto C; Chas M; Bédouet L; Etienne C; Arbion F; Body G; Ouldamer L
    Gynecol Obstet Fertil Senol; 2017 Apr; 45(4):215-223. PubMed ID: 28359803
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. ALDH1A1 mRNA expression in association with prognosis of triple-negative breast cancer.
    Liu Y; Baglia M; Zheng Y; Blot W; Bao PP; Cai H; Nechuta S; Zheng W; Cai Q; Shu XO
    Oncotarget; 2015 Dec; 6(38):41360-9. PubMed ID: 26462023
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Host genotype and tumor phenotype of chemokine decoy receptors integrally affect breast cancer relapse.
    Yu KD; Wang X; Yang C; Zeng XH; Shao ZM
    Oncotarget; 2015 Sep; 6(28):26519-27. PubMed ID: 26314842
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Mutation profiling and microsatellite instability in stage II and III colon cancer: an assessment of their prognostic and oxaliplatin predictive value.
    Gavin PG; Colangelo LH; Fumagalli D; Tanaka N; Remillard MY; Yothers G; Kim C; Taniyama Y; Kim SI; Choi HJ; Blackmon NL; Lipchik C; Petrelli NJ; O'Connell MJ; Wolmark N; Paik S; Pogue-Geile KL
    Clin Cancer Res; 2012 Dec; 18(23):6531-41. PubMed ID: 23045248
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Risk of mortality by histologic type of breast cancer in the United States.
    Li CI
    Horm Cancer; 2010 Jun; 1(3):156-65. PubMed ID: 21761358
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.